Two clinical-grade daily blends. Every dose matched to human clinical trial evidence. Zero proprietary blends. Zero compromise.
Total mushroom complex in the category's best-selling daily blend. Clinical minimum for lion's mane alone: 1,000mg fruiting body. The gap is not disclosed.
Of supplements contain at least one proprietary blend, making effective-dose verification by the consumer impossible. Formulated by marketing budget, not clinical evidence.
NR dose in a leading NAD+ longevity product. The published efficacy threshold: 300mg. Every serving falls below the minimum. No disclosure required.
Eight ingredients targeting cellular antioxidant defence, NAD+ biosynthesis, mitochondrial nitric oxide efficiency, and neurotrophin support — each at or exceeding the minimum effective dose established in human clinical trials. Click any ingredient to see the mechanism.
Eleven ingredients across two layers: acute-acting compounds that engage within 30–90 minutes, and chronic-building compounds that reinforce neuroplasticity over weeks. No caffeine. No adenosine rebound. No crash.
We’re building the first brand that is both.
| Brand | Lion’s Mane | NAD+ Precursor | Senolytic | Bacopa | Mitophagy | Full Disclosure |
|---|---|---|---|---|---|---|
| AG1 | <50mg — hidden | None | None | None | None | Proprietary blends |
| Four Sigmatic Think | 375–500mg | None | None | None | None | Partial |
| Elysium Basis | None | 250mg NR (below MED) | None | None | None | ✓ |
| Tru Niagen | None | 300mg NR | None | None | None | ✓ |
| Timeline Mitopure | None | None | None | None | 500mg UA | ✓ |
| Aevum | 1,000mg fruiting body | 500mg NMN (Longevity) | Via Chaga beta-glucans | 300mg Bacognize® (Nootropic) | Beet Root NO pathway | Full — zero blends |
The first 200 customers are selected for engagement, not just purchase. Real products. Optional biomarker tracking. The beginning of an internal clinical dataset — not a customer satisfaction survey.
Science-first. Dose-honest. Not a greens powder.